Technology · Synthetic biology investment

Synthetic biology investment in Central African Republic in 2026

Investment in synthetic biology in the Central African Republic in 2026 was 1 $ — the 73rd result among 197 countries. The lack of venture capital, political instability, and a weak scientific and technical base make the country unattractive for high-tech investors. Funds are directed toward basic needs — food security and poverty reduction — not experimental biotechnologies.

Data for 2026 · unit: $
Position

Central African Republic world ranking

#73 / 197

Country position on the scale from last to first place for this indicator.

CF
#73
#197#1
Trend

Change over time

Change in indicator over the available period.

0
2010
0
2020
1
2025
1
2026

Values — $

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Synthetic biology investment in Central African Republic — how much?
Based on 2026 data — 1 $. This is rank #73 out of 197 countries.
What is Central African Republic's rank by Synthetic biology investment?
Central African Republic ranks #73 out of 197 countries in the world ranking by «Synthetic biology investment».
How has Synthetic biology investment changed in Central African Republic?
Over the available period the indicator changed from 0 to 1 $.